Diffuse follicle center lymphoma, lymph nodes of head, face, and neck
ICD-10 C82.51 is a billable code used to indicate a diagnosis of diffuse follicle center lymphoma, lymph nodes of head, face, and neck.
Diffuse follicle center lymphoma (DFCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells within the follicle centers of lymphoid tissue. This specific code pertains to cases where the lymphoma is primarily located in the lymph nodes of the head, face, and neck. Clinically, patients may present with painless lymphadenopathy in these regions, and the disease can be associated with systemic symptoms. DFCL is typically diagnosed through a combination of imaging studies, such as CT scans, and histopathological examination of lymph node biopsies. The prognosis and treatment options depend on various factors, including the stage of the disease, presence of B-symptoms (fever, night sweats, weight loss), and overall patient health. Treatment often involves chemotherapy, immunotherapy, or radiation therapy, tailored to the individual patient's needs and disease characteristics.
Detailed clinical notes on lymph node involvement, staging, and treatment plans.
Patients presenting with lymphadenopathy, undergoing chemotherapy, or receiving follow-up care.
Ensure accurate staging and documentation of any B-symptoms to support coding.
Histopathological reports confirming diagnosis and subtype of lymphoma.
Biopsy specimens from lymph nodes being analyzed for lymphoma classification.
Clear documentation of findings is crucial for accurate coding and billing.
Used when a biopsy is performed to confirm the diagnosis of diffuse follicle center lymphoma.
Pathology report detailing the findings and diagnosis.
Pathologists must ensure accurate reporting of lymphoma subtype.
B-symptoms refer to systemic symptoms such as fever, night sweats, and weight loss that can indicate a more aggressive disease course. Documenting these symptoms is crucial for accurate staging and treatment planning.
